AVENUE THERAPEUTICS, INC. Payments of Stock Issuance Costs
AVENUE THERAPEUTICS, INC. (ATXI) reported Payments of Stock Issuance Costs of $508.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2023-03-31
- AVENUE THERAPEUTICS, INC. payments of stock issuance costs for the quarter ending 2019-12-31 was $0.00, a 100.00% decline year-over-year.
- AVENUE THERAPEUTICS, INC. payments of stock issuance costs for the quarter ending 2019-09-30 was $0.00.
- AVENUE THERAPEUTICS, INC. payments of stock issuance costs for the quarter ending 2019-06-30 was $12.00K.
- AVENUE THERAPEUTICS, INC. payments of stock issuance costs for the quarter ending 2019-03-31 was $2.65M.
- AVENUE THERAPEUTICS, INC. payments of stock issuance costs for fiscal 2022 was $508.00K, a 23.38% decline from fiscal 2021.
- AVENUE THERAPEUTICS, INC. payments of stock issuance costs for fiscal 2021 was $663.00K.
- AVENUE THERAPEUTICS, INC. payments of stock issuance costs for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- AVENUE THERAPEUTICS, INC. payments of stock issuance costs for fiscal 2019 was $2.67M, a 197.99% increase from fiscal 2018.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|
| 2022-12-31 | $508.00K 10-K · filed 2023-03-31 | |||
| 2021-12-31 | $663.00K 10-K · filed 2023-03-31 | |||
| 2020-12-31 | $0.00 10-K · filed 2021-03-31 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $0.00 derived: sum of 2 quarters · filed 2021-03-31 | $12.00K derived: sum of 3 quarters · filed 2021-03-31 | $2.67M 10-K · filed 2021-03-31 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $12.00K derived: sum of 2 quarters · filed 2020-11-04 | $2.67M 10-Q · filed 2020-11-04 | $3.56M derived: sum of 4 quarters · filed 2020-11-04 |
| 2019-06-30 | $12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $2.67M 10-Q · filed 2020-08-14 | $3.56M derived: sum of 3 quarters · filed 2020-08-14 | $3.56M derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-03-31 | $2.65M 10-Q · filed 2020-05-11 | $3.55M derived: sum of 2 quarters · filed 2020-05-11 | $3.55M derived: sum of 3 quarters · filed 2020-05-11 | $3.55M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $895.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $895.00K derived: sum of 2 quarters · filed 2020-03-30 | $895.00K derived: sum of 3 quarters · filed 2020-03-30 | $895.00K 10-K · filed 2020-03-30 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $0.00 derived: sum of 2 quarters · filed 2018-11-14 | $0.00 10-Q · filed 2018-11-14 | $0.00 derived: sum of 4 quarters · filed 2019-05-13 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $0.00 10-Q · filed 2018-08-14 | $0.00 derived: sum of 3 quarters · filed 2019-05-13 | $268.00K derived: sum of 4 quarters · filed 2019-05-13 |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-13 | $0.00 derived: sum of 2 quarters · filed 2019-05-13 | $268.00K derived: sum of 3 quarters · filed 2019-05-13 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $268.00K derived: sum of 2 quarters · filed 2019-03-12 | $3.71M 10-K · filed 2019-03-12 | |
| 2017-09-30 | $268.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $3.71M 10-Q · filed 2018-11-14 | ||
| 2017-06-30 | $3.45M 10-Q · filed 2018-08-14 |